应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01355 生物系统工程
休市中 08-14 16:08:34
0.175
+0.001
+0.57%
最高
0.177
最低
0.157
成交量
133.75万
今开
0.167
昨收
0.174
日振幅
11.49%
总市值
3.13亿
流通市值
3.13亿
总股本
17.90亿
成交额
22.22万
换手率
0.07%
流通股本
17.90亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
生物系统工程(01355)完成发行5,000万港元可换股债券 最高将把股本扩大至15.16亿股
公告速递 · 08-05
生物系统工程(01355)完成发行5,000万港元可换股债券 最高将把股本扩大至15.16亿股
生物系统工程(01355)完成发行本金总额为5000万港元的可换股债券
智通财经 · 08-05
生物系统工程(01355)完成发行本金总额为5000万港元的可换股债券
生物系统工程(01355)拟增加法定股本
智通财经 · 08-05
生物系统工程(01355)拟增加法定股本
生物系统工程(01355)拟将法定股本由2,000万港元增至1亿港元 以备未来融资需求
公告速递 · 08-05
生物系统工程(01355)拟将法定股本由2,000万港元增至1亿港元 以备未来融资需求
生物系统工程(01355)拟于2026年8月25日召开股东特别大会 议决增加法定股本至1亿港元
公告速递 · 08-05
生物系统工程(01355)拟于2026年8月25日召开股东特别大会 议决增加法定股本至1亿港元
生物系统工程7月无新增发行或股份变动
公告速递 · 07-31
生物系统工程7月无新增发行或股份变动
朸浚国际(01355)拟发行5,000万港元可换股债券 将于7月27日召开股东特别大会表决
公告速递 · 07-08
朸浚国际(01355)拟发行5,000万港元可换股债券 将于7月27日召开股东特别大会表决
朸浚国际6月无新增发行或股份变动
公告速递 · 07-02
朸浚国际6月无新增发行或股份变动
生物系统工程(01355)拟按“2供1”基准进行供股 最高净筹约3900万港元
智通财经 · 06-24
生物系统工程(01355)拟按“2供1”基准进行供股 最高净筹约3900万港元
朸浚国际5月无新增发行或股份变动
公告速递 · 06-02
朸浚国际5月无新增发行或股份变动
生物系统工程(01355):嘉林资本获委任为独立财务顾问
智通财经 · 06-01
生物系统工程(01355):嘉林资本获委任为独立财务顾问
生物系统工程(01355)拟发行本金总额为5000万港元的可换股债券
智通财经 · 05-27
生物系统工程(01355)拟发行本金总额为5000万港元的可换股债券
朸浚国际4月股份变动月报:股本维持不变
公告速递 · 05-04
朸浚国际4月股份变动月报:股本维持不变
朸浚国际(01355)2025年营收达5.13亿元 住宿与医疗美容并举致年度亏损扩大
公告速递 · 04-30
朸浚国际(01355)2025年营收达5.13亿元 住宿与医疗美容并举致年度亏损扩大
朸浚国际拟回购最多10%股份
公告速递 · 04-30
朸浚国际拟回购最多10%股份
朸濬国际(01355)拟更名为“生物系统工程”
智通财经 · 04-28
朸濬国际(01355)拟更名为“生物系统工程”
朸浚国际(01355.HK):建议采纳购股权计划
中金财经 · 04-28
朸浚国际(01355.HK):建议采纳购股权计划
朸濬国际(01355)建议采纳购股权计划
智通财经 · 04-28
朸濬国际(01355)建议采纳购股权计划
朸濬国际(01355)拟更名为“生物系统工程有限公司”
智通财经 · 04-22
朸濬国际(01355)拟更名为“生物系统工程有限公司”
朸浚国际3月无新增发行或股份变动
公告速递 · 03-31
朸浚国际3月无新增发行或股份变动
公司概况
公司名称:
生物系统工程
所属市场:
SEHK
上市日期:
--
主营业务:
生物系统工程有限公司(原名:朸浚国际集团控股有限公司)是一家主要从事住宿业务的投资控股公司。该公司透过两个分部运营业务。住宿业务分部主要从事住宿运营,提供物业及设施管理服务,同时亦提供住宿咨询服务及其他相关业务。医疗保健及美容业务分部主要销售生物再生、胶原蛋白及抗衰老护肤产品。
发行价格:
--
{"stockData":{"symbol":"01355","market":"HK","secType":"STK","nameCN":"生物系统工程","latestPrice":0.175,"timestamp":1786694914663,"preClose":0.174,"halted":0,"volume":1337500,"delay":0,"changeRate":0.005747126436781614,"floatShares":1789999999,"shares":1789999999,"eps":-0.0451,"marketStatus":"休市中","change":0.001,"latestTime":"08-14 16:08:34","open":0.167,"high":0.177,"low":0.157,"amount":222195,"amplitude":0.114943,"askPrice":0.175,"askSize":20000,"bidPrice":0.161,"bidSize":20000,"shortable":0,"etf":0,"ttmEps":-0.024,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":7,"adr":0,"listingDate":1310659200000,"exchange":"SEHK","adjPreClose":0.174,"openAndCloseTimeList":[[1786671000000,1786680000000],[1786683600000,1786694400000]],"volumeRatio":1.0105016621106717,"lotSize":20000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01355/wiki","defaultTab":"wiki","newsList":[{"id":"1190088109","title":"生物系统工程(01355)完成发行5,000万港元可换股债券 最高将把股本扩大至15.16亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1190088109","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190088109?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:12","pubTimestamp":1785921137,"startTime":"0","endTime":"0","summary":"生物系统工程有限公司8月5日公告,根据特别授权发行的可换股债券已于当日完成。此次发行本金总额为5,000万港元的可换股债券全部配售予认购人,认购价以抵销贷款方式支付,相关贷款偿还责任已全面履行。截至公告日期,尚无可换股债券被转换。公告显示,可换股债券完成前,公司已发行股份总数为1,193,065,160股。届时,认购人持股将增至668,509,665股,占比44.11%;历宝珊及关文焯的持股数量保持不变,分别占比6.20%及4.36%;公众股东持股仍为687,114,140股,占比45.33%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657512980","title":"生物系统工程(01355)完成发行本金总额为5000万港元的可换股债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2657512980","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657512980?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:06","pubTimestamp":1785920813,"startTime":"0","endTime":"0","summary":"智通财经APP讯,生物系统工程(01355)发布公告,于认购及清贘协议所载的所有先决条件已获达成,且已于2026年8月5日完成。于完成后,本金总额为5000万港元的可换股债券已发行予认购人。认购人以抵销抵销贷款的方式支付可换股债券的认购价。本公司就抵销贷款的还款责任已获全面履行。于本公告日期,概无可换股债券予以转换。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BNDW","BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657592915","title":"生物系统工程(01355)拟增加法定股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2657592915","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657592915?lang=zh_cn&edition=full","pubTime":"2026-08-05 12:10","pubTimestamp":1785903012,"startTime":"0","endTime":"0","summary":"智通财经APP讯,生物系统工程(01355)发布公告,公司董事会建议通过增设80亿股股份,将本公司法定股本由2000万港元(分为20亿股每股面值0.01港元的本公司股份(股份))增加至1亿港元(分为100亿股股份),而该等股份于发行后将于各方面与现有股份享有同等地位(增加法定股本)。于本公告日期,已发行11.93亿股股份,而8.069亿股股份为法定但未发行。为应对本集团的潜在增长及发展并为本公司于未来集资时提供更大灵活性,董事会认为增加法定股本符合本公司及其股东(股东)的整体利益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129809863","title":"生物系统工程(01355)拟将法定股本由2,000万港元增至1亿港元 以备未来融资需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1129809863","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129809863?lang=zh_cn&edition=full","pubTime":"2026-08-05 12:05","pubTimestamp":1785902748,"startTime":"0","endTime":"0","summary":"2026年8月5日,生物系统工程有限公司发布公告称,董事会建议在股东特别大会上提交普通决议案,拟将公司法定股本由现有的20,000,000港元增至100,000,000港元。换言之,此次将新增8,000,000,000股法定股份,新增股份在发行后与现有股份享有同等地位。截至公告日,公司已发行1,193,065,160股,尚有806,934,840股虽已获授权但未发行。公司表示,扩大法定股本旨在为集团潜在增长及未来融资提供更大灵活性。有关增资的详细信息及股东特别大会通告的通函,预计将于2026年8月5日寄发予股东。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133498766","title":"生物系统工程(01355)拟于2026年8月25日召开股东特别大会 议决增加法定股本至1亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133498766","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133498766?lang=zh_cn&edition=full","pubTime":"2026-08-05 06:05","pubTimestamp":1785881157,"startTime":"0","endTime":"0","summary":"生物系统工程有限公司8月5日公告,将于2026年8月25日15时在香港湾仔港湾道26号华润大厦30楼3008-3009室召开股东特别大会,审议一项普通决议案:。如于大会当日12时正香港天文台发出黑色暴雨警告或八号或以上热带气旋信号,或政府宣布“极端情况”生效,股东特别大会将延期,届时公司将另行公告重新安排的会议时间、地点。截至公告日,公司董事会成员为:执行董事李芷欣;非执行董事张政武、胡性龙;独立非执行董事吴吉林、林长盛、苏彦威。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158680842","title":"生物系统工程7月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1158680842","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158680842?lang=zh_cn&edition=full","pubTime":"2026-07-31 18:02","pubTimestamp":1785492136,"startTime":"0","endTime":"0","summary":"据生物系统工程有限公司于2026年7月31日发布的月报显示,公司在2026年7月份期间并未进行任何新的股份发行、购回或注销活动,股本结构整体保持稳定。根据公告披露,截至2026年7月31日,公司法定股本仍为20,000,000港元,对应已授权发行股份总数2,000,000,000股,面值每股0.01港元;已发行股份数目则维持在1,193,065,160股,库藏股份数量为0股,较上月底均无变动。公司同时声明,其在所有股份事务处理过程中已遵守香港联交所《上市规则》及其他相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199126513","title":"朸浚国际(01355)拟发行5,000万港元可换股债券 将于7月27日召开股东特别大会表决","url":"https://stock-news.laohu8.com/highlight/detail?id=1199126513","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199126513?lang=zh_cn&edition=full","pubTime":"2026-07-08 06:06","pubTimestamp":1783461995,"startTime":"0","endTime":"0","summary":"7月8日,朸浚国际发布股东特别大会通告,公司将于2026年7月27日15时在香港湾仔港湾道26号华润大厦30楼3008-3009室举行股东特别大会,对发行可换股债券等多项议案进行表决。根据公告,公司已于2026年5月26日与Osibao Cosmetics International Limited签订《认购及清偿协议》,拟作为发行人向该认购人发行本金总额5,000万港元的可换股债券。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181397390","title":"朸浚国际6月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1181397390","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181397390?lang=zh_cn&edition=full","pubTime":"2026-07-02 11:51","pubTimestamp":1782964317,"startTime":"0","endTime":"0","summary":"2026年7月2日,朸浚国际(01355)发布截至2026年6月30日的股份变动月报表。公告显示,公司注册股本保持在2,000,000,000股,每股面值港币0.01元,总注册股本为港币20,000,000;期末已发行股份总数为1,193,065,160股,与上月底持平,公司并无发行新股或回购、注销及库藏股活动。\n公司确认其公开持股量满足香港联合交易所有限公司的相关规定,同时于报告期内并未发生股份期权、股权激励计划及可换股票据等方面的变动,公司继续严格遵守香港联交所《上市规则》及有关法律法规。该公告由公司秘书李柏聪代表董事会签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645689094","title":"生物系统工程(01355)拟按“2供1”基准进行供股 最高净筹约3900万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645689094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645689094?lang=zh_cn&edition=full","pubTime":"2026-06-24 19:54","pubTimestamp":1782302081,"startTime":"0","endTime":"0","summary":"智通财经APP讯,生物系统工程 发布公告,公司建议基于本公告日期已发行11.93亿股股份按于记录日期每持有2股现有股份获发1股供股股份的基准,以每股供股股份0.068港元的认购价进行供股。经扣除与供股相关的估计开支后,供股的估计所得款项净额将约为3900万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176540783","title":"朸浚国际5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1176540783","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176540783?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:46","pubTimestamp":1780400775,"startTime":"0","endTime":"0","summary":"朸浚国际于2026年6月2日发布截至2026年5月31日的证券变动月报表。本次月报显示,公司注册股本维持2,000,000,000股普通股不变,每股面值为HKD0.01,注册股本总额为HKD20,000,000;本月末已发行股份与上月末持平,均为1,193,065,160股,库存股数量为0股。根据公告,报告期内公司无新增股份发行、购回、注销或库藏股变动,股本状态保持稳定。公司并无与股份期权、权证或可换股票据等相关的新增或变动事项,亦无其他关于发行人股份的协议或安排新增情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640921950","title":"生物系统工程(01355):嘉林资本获委任为独立财务顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=2640921950","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640921950?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:31","pubTimestamp":1780324305,"startTime":"0","endTime":"0","summary":"智通财经APP讯,生物系统工程(01355)发布公告,获独立董事委员会之批准,嘉林资本有限公司,一间根据证券及期货条例可从事第6类(就机构融资提供意见)受规管活动的持牌法团,已获委任为独立财务顾问,以就认购及清偿协议及其项下拟进行之交易(包括授出特别授权)向独立董事委员会及独立股东提供意见。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638529797","title":"生物系统工程(01355)拟发行本金总额为5000万港元的可换股债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2638529797","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638529797?lang=zh_cn&edition=full","pubTime":"2026-05-27 08:12","pubTimestamp":1779840743,"startTime":"0","endTime":"0","summary":"智通财经APP讯,生物系统工程(01355)发布公告,于2026年5月26日,本公司与认购人订立认购及清贘协议,据此,本公司有条件同意发行及认购人有条件同意按其面值认购本金总额为5000万港元的可换股债券并于完成时透过抵销股东贷款支付认购价。可换股债券可根据初始转换价每股转换股份0.155港元悉数转换为3.23亿股转换股份。假设已发行股份并无变动及按初始转换价,转换股份相当于现有已发行股份约27.04%,及相当于于可换股债券获悉数转换后,本公司经配发及发行转换股份而扩大的已发行股份约21.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355","BNDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138228515","title":"朸浚国际4月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1138228515","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138228515?lang=zh_cn&edition=full","pubTime":"2026-05-04 12:22","pubTimestamp":1777868549,"startTime":"0","endTime":"0","summary":"朸浚国际于2026年5月4日发布截至2026年4月30日的证券变动月报表。报告显示,公司在4月份未有新增股份发行、购回或注销,整体股本结构保持稳定。根据公告,截至2026年4月30日,公司注册股本维持为2,000,000,000股普通股,面值每股0.01港元,总额为20,000,000港元,与此前月份保持一致。本次公告由公司秘书李柏聰签署,朸浚国际重申已严格遵守香港联合交易所《上市规则》和相关法律法规的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102441062","title":"朸浚国际(01355)2025年营收达5.13亿元 住宿与医疗美容并举致年度亏损扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=1102441062","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102441062?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:21","pubTimestamp":1777540906,"startTime":"0","endTime":"0","summary":"朸浚国际公布截至2025年12月31日止年度业绩,报告期内集团收入同比增长25.9%至5.13亿元,较上一财年的4.07亿元显著上升。受经营成本、资产减值及信贷损失拨备等影响,年内录得亏损4,537.8万港元,较上年度的3,976.0万港元有所扩大;同期全面亏损则为4,900.1万港元,高于上年度的3,759.6万港元。整体而言,朸浚国际在2025年取得收入增长的同时,仍因多项成本与支出上升而导致亏损进一步扩大。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"朸浚国际(01355)2025年营收达5.13亿元 住宿与医疗美容并举致年度亏损扩大","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186550153","title":"朸浚国际拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1186550153","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186550153?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:21","pubTimestamp":1777540878,"startTime":"0","endTime":"0","summary":"朸浚国际近日在港交所披露公告称,董事会已获股东大会授予股份购回的一般授权,规模最高可达公司已发行股份总数的10%。据公告披露,朸浚国际目前已发行股份总数为1,193,065,160股,如授权获行使,最多可回购的股份数量为119,306,516股。朸浚国际于公告中强调,所有股份购回须在联交所或相关监管规定允许的范围内进行。公司提醒股东在指定期限内办理股份过户,如回购授权最终获股东大会通过,后续购回将按经批注程序推进。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"朸浚国际拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630304721","title":"朸濬国际(01355)拟更名为“生物系统工程”","url":"https://stock-news.laohu8.com/highlight/detail?id=2630304721","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630304721?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:36","pubTimestamp":1777379818,"startTime":"0","endTime":"0","summary":"智通财经APP讯,朸濬国际(01355)发布公告,本公司名称已由“Legend Strategy International Holdings Group Company Limited 朸濬国际集团控股有限公司”更改为“ Biosysen Limited 生物系统工程有限公司”。本公司于联交所买卖股份的英文股份简称将由“ LEGEND STRAT”更改为“BIOSYSEN”,中文股份简称将由“朸濬国际”更改为“生物系统工程”,自2026年5月4日上午九时正起生效。本公司的股份代号保持不变,仍为“1355”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01355","BK1164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630337948","title":"朸浚国际(01355.HK):建议采纳购股权计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2630337948","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630337948?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:57","pubTimestamp":1777366621,"startTime":"0","endTime":"0","summary":"格隆汇4月28日丨朸浚国际(01355.HK)公告,公司建议根据香港联合交易所有限公司颁布的香港联合交易所有限公司证券上市规则第17章的规定采纳购股权计划。购股权计划旨在供董事会向合资格参与者授出购股权,以作为彼等对集团所作出贡献或潜在贡献之激励或奖励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260428/32184093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630761483","title":"朸濬国际(01355)建议采纳购股权计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2630761483","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630761483?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:40","pubTimestamp":1777365641,"startTime":"0","endTime":"0","summary":"智通财经APP讯,朸濬国际(01355)发布公告,董事会建议采纳一项购股权计划以供公司股东批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435242.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629289014","title":"朸濬国际(01355)拟更名为“生物系统工程有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2629289014","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629289014?lang=zh_cn&edition=full","pubTime":"2026-04-22 18:01","pubTimestamp":1776852098,"startTime":"0","endTime":"0","summary":"智通财经APP讯,朸濬国际(01355)发布公告,股东于2026年4月1日举行的股东特别大会上通过有关更改公司名称的特别决议案后,本公司英文名称已由“Legend Strategy International Holdings Group Company Limited”更改为“ Biosysen Limited”,并采纳“生物系统工程有限公司”为本公司新双重外文名称,以取代“朸濬国际集团控股有限公司”。开曼群岛公司注册处处长已于2026年4月2日发出更改公司名称注册证书。本公司正向香港公司注册处申请非香港注册公司名称变更注册证书,并已完成必要的备案程序,但截至本公告日期,该证书尚未签发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109398975","title":"朸浚国际3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1109398975","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109398975?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:02","pubTimestamp":1774954921,"startTime":"0","endTime":"0","summary":"朸浚国际于2026年3月31日披露截至2026年3月31日的股份变动月报表。报告显示,截至本月末,公司法定(注册)股本维持在2,000,000,000股,对应法定股本为20,000,000港元,较上月底无变化。公司已发行普通股数量为1,193,065,160股,与上月底持平,库藏股数依旧为0股,本月无新增发行、购回或注销活动。公告提及,所有发行或转让行为均已获得董事会正式授权并遵守了适用的上市规则及相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legend-strategy.com","stockEarnings":[{"period":"1week","weight":0.3359},{"period":"1month","weight":0.3672},{"period":"3month","weight":0.4228},{"period":"6month","weight":0.3359},{"period":"1year","weight":0.7857},{"period":"ytd","weight":0.699}],"compareEarnings":[{"period":"1week","weight":-0.0215},{"period":"1month","weight":0.0177},{"period":"3month","weight":-0.0326},{"period":"6month","weight":-0.0546},{"period":"1year","weight":-0.0158},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"生物系统工程有限公司(原名:朸浚国际集团控股有限公司)是一家主要从事住宿业务的投资控股公司。该公司透过两个分部运营业务。住宿业务分部主要从事住宿运营,提供物业及设施管理服务,同时亦提供住宿咨询服务及其他相关业务。医疗保健及美容业务分部主要销售生物再生、胶原蛋白及抗衰老护肤产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":-0.000587},{"month":2,"riseRate":0.538462,"avgChangeRate":-0.013312},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.0275},{"month":4,"riseRate":0.384615,"avgChangeRate":0.022504},{"month":5,"riseRate":0.461538,"avgChangeRate":0.103733},{"month":6,"riseRate":0.384615,"avgChangeRate":-0.003583},{"month":7,"riseRate":0.307692,"avgChangeRate":-0.034837},{"month":8,"riseRate":0.230769,"avgChangeRate":-0.090501},{"month":9,"riseRate":0.615385,"avgChangeRate":0.112592},{"month":10,"riseRate":0.307692,"avgChangeRate":0.050823},{"month":11,"riseRate":0.153846,"avgChangeRate":-0.055893},{"month":12,"riseRate":0.615385,"avgChangeRate":0.027648}],"exchange":"SEHK","name":"生物系统工程","nameEN":"BIOSYSEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物系统工程(01355)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物系统工程(01355)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物系统工程,01355,生物系统工程股票,生物系统工程股票老虎,生物系统工程股票老虎国际,生物系统工程行情,生物系统工程股票行情,生物系统工程股价,生物系统工程股市,生物系统工程股票价格,生物系统工程股票交易,生物系统工程股票购买,生物系统工程股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物系统工程(01355)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物系统工程(01355)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}